Web6 Mar 2024 · Lastest business and financial news on stocks, indices, commodities, bonds and many more like analyst opinions on Markets Insider. Web14 Apr 2024 · Amir Reichman, CEO of biotechnology company BiondVax Pharmaceuticals (NASDAQ: BVXV), recently presented at the 17th annual BIO-Europe Spring conference in Basel, Switzerland. Hosted by EBD Group, the three-day in-person conference, which was held March 20-22, brought together more than 2,800 … Continue reading →
Pareteum Corporation Announces 2024 Financial Results
Web13 Apr 2024 · CEO John Climaco reported on company developments at the Virtual Investor GBM Spotlight Event on April 4; For decades, medical science has sought an effective means of stopping the most common primary brain cancer in adults in its tracks and keeping it from recurring. In spite of multimodal treatment that includes surgical removal, … Web17 Jun 2024 · Pareteum Corporation Announces 2024 Financial Results June 17, 2024 - 2024 total revenue of $69.6 million, 12% year-over-year growth - Net loss attributable to … jeremy rickards washington
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient …
WebPreviously, Cesar was a Vice President, Customer Success & Partners at Welkin Health and also held positions at Pareteum, Dynatrace, Compuware, C&A, Warner Music Group, The … Web11 Apr 2024 · CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments, recently reported the enrolment of the first patient in Switzerland as a participant in its ongoing potentially pivotal global trial evaluating Berubicin for the treatment … Continue reading → Web10 Nov 2024 · Pareteum Investor Relations Contacts:Investor Relations +1 (646) 975-0400 [email protected] ... pacifica hybrid 2021 limited vs touring